HOME >> BIOLOGY >> NEWS
Amgen's decision to block reinstatement of GDNF is faulted by a leading Parkinson's advocacy group

effects of Parkinson's disease. Since the trial was halted last summer, many of these people, supported by organizations and thousands of well-wishers from around the Parkinson's community, have pleaded with Amgen to reinstate those subjects who wish to continue with the treatment and are willing to be carefully followed to generate ongoing data. We understand and fully accept that such reinstatement of treatment should take place only with appropriate waivers that would hold the company harmless in event of any complications, whether foreseen or unforeseen, and with the approval of the relevant Institutional Review Boards."

"The safety issues of neutralizing antibodies (found in some of the human subjects) and of cerebellar degeneration involving high-dosage GDNF (in some non-human primate subjects) need to be investigated and understood. If subjects are willing to offer themselves for continuing GDNF infusion with all of these safety concerns fully explained and understood by the subjects, then the Parkinson community science as well as patients can gain much new information related to the safety of GDNF infusions."

"In summary, the decision is a mistake because it denies the patients and their doctors the opportunity to continue with a potentially useful, albeit yet unproven, treatment, and it denies us all the opportunity to gather more scientific data about the long-term effects of GDNF. We hope very much that this company, which has long held a position of high respect in the business and health communities, will consider reversing its decision, and soon. In the meantime, the coalition of patient-voluntary groups which besides PDF includes the Parkinson's Action Network and the Parkinson's Pipeline Project -- will continue fighting for patients' interests as long as it takes."


'"/>

Contact: Christiana Evers
cevers@pdf.org
Parkinson's Disease Foundation
11-Feb-2005


Page: 1 2

Related biology news :

1. A nurse makes the decision on who will live
2. Cells use noise to make cell-fate decisions
3. Group decisions: From compromise to leadership in pigeon homing
4. AIUM supports FDA decision to deny over-the-counter use of handheld doppler fetoscopes
5. Titans of biodiversity science call for united, authoritative voice to inform decision-makers
6. Dover intelligent design decision to be topic of national forum
7. Honeybee decision-making ability rivals any department committee
8. Even at small scales, the big decisions are made at the water cooler
9. Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices
10. Ethical decision-making at bioscience companies
11. Dover decision is good for long-term economic and scientific strength

Post Your Comments:
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ... Sensors Market in Smart Mobile Devices " report ... 2014 was a watershed year for fingerprint sensors in ... Pay,. Apple gave fingerprint sensors a raison d,etre in ... sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
(Date:5/29/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... that results of a large, European single-center experience ... hepatic metastases with the Delcath Hepatic CHEMOSAT ® ... abstract at the American Society of Clinical Oncology ...
(Date:5/29/2015)... , May 28, 2015 Research and ... of Jain PharmaBiotech,s new report "Cytogenetics - ... This report deals with cytogenetics in ... mainly to describe the chromosome structure and identify ... molecular biology, it is also referred to as ...
(Date:5/29/2015)... Translation is frequently listed as one of the ways ... in a way that is right for a company, translation ... or service offering. , Here are some of the ... a company's bottom line: , 1.    Attract bigger audience. , With ... use, why not offer it globally? Nelson Mandela once said: ...
(Date:5/28/2015)... , May 28, 2015 ... ) has announced the addition of ... - Technologies, Markets and Companies"  to ... ,This report describes and evaluates animal ... medicine and pharmaceuticals as well as ...
Breaking Biology Technology:Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3Three Ways Translation Can Help Businesses Grow 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3
Cached News: